Morgan Stanley on Eli Lilly (LLY) following scripts: 'We see ~6% upside to '26 M+Z ests'

March 27, 2026 8:32 AM

Morgan Stanley analyst Terence Flynn reiterated an Overweight rating and $1,313.00 price target on Eli Lilly (NYSE: LLY)The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

StreetInsider

Log in to your account:

Morgan Stanley on Eli Lilly (LLY) following scripts: 'We see ~6% upside to '26 M+Z ests'

Categories